Lumbar-Stenosis
发表于 2025-3-23 11:16:07
http://reply.papertrans.cn/48/4711/471002/471002_11.png
Gossamer
发表于 2025-3-23 16:12:43
Treatment Strategies in Multiple Myeloma: Biotherapy with Interferons,100 000 persons in China to approximately four per 100 000 in the United States and most Western industrialized countries. Blacks are affected twice as often as Caucasians, and men more often than women. Multiple myeloma is clearly an age-dependent disease, with affected individuals having a mean ag
砍伐
发表于 2025-3-23 20:58:49
http://reply.papertrans.cn/48/4711/471002/471002_13.png
exercise
发表于 2025-3-23 23:36:32
http://reply.papertrans.cn/48/4711/471002/471002_14.png
tenuous
发表于 2025-3-24 05:59:24
Cutaneous Lymphomas: A Heterogeneous Group of Lymphoproliferative Disorders at Least in Part Sensitous lymphoproliferative disorders can present in the skin alone, in the skin and extracutaneous sites, or as extracutaneous disease with secondary skin involvement. In a strict sense, they are lymphoproliferative disorders primarily manifesting in the skin and being confined to the skin for ever or
Criteria
发表于 2025-3-24 09:21:02
Current Therapy Strategies for Malignant Melanoma with Special Regard to Immunotherapy with Cytokin(MM) develops as a result of neoplastic transformation of melanocytes either in or near a precursor lesion, e.g., a nevus, or de novo in normal skin. MM is one of the most dangerous malignant tumors in general and the most common reason for the death of patients with a cutaneous neoplasia . MM
FLIRT
发表于 2025-3-24 11:34:11
http://reply.papertrans.cn/48/4711/471002/471002_17.png
abnegate
发表于 2025-3-24 14:54:25
Interferons in the Treatment of Genitourinary Tumors,s well as against experimental tumor models in animal experiments has stimulated the investigation of these cytokines in the treatment of human malignancy. Looking at the innumerous case reports and studies reported so far the rationale for using interferons in the treatment of genitourinary tumors
accessory
发表于 2025-3-24 22:06:03
http://reply.papertrans.cn/48/4711/471002/471002_19.png
增长
发表于 2025-3-25 00:55:21
http://reply.papertrans.cn/48/4711/471002/471002_20.png